Amneal Pharmaceuticals has received FDA approval for erythromycin tablets USP, in 250 mg and 500 mg strengths. The product is a therapeutic equivalent for the reference listed drug (RLD) erythromycin tablets from Arbor Pharmaceuticals and is an immediate release oral tablet. They are packaged in 100-count bottles and are now available to wholesalers, distributors, and direct.